SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    ParkinDM, WhelanSL, FerlayJ, RaymondL, YoungJ, eds. Cancer incidence in five continents. Vol. VII, IARC Sci Publ Vol. 143, Lyon: International Agency for Research on Cancer, 1997.
  • 2
    Anderson DE, Badzioch MD. Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst 1992; 84: 111417.
  • 3
    Rosenblatt KA, Thomas DB, McTiernan A, Austin MA, Stalsberg H, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF, et al. Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst 1991; 83: 84954.
  • 4
    Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 67689.
  • 5
    Basham VM, Lipscombe JM, Ward J, Gayther SA, Ponder BAJ, Easton D, Pharoah P. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 2002, 4: R2.
  • 6
    Struewing JP, Coriaty ZM, Ron E, Livoff A, Konichezky M, Cohen P, Resnick MB, Lifzchiz-Mercerl B, Lew S, Iscovich J. Founder BRCA1/2 mutations among male patients with breast cancer in Israel. Am J Hum Genet 1999; 65: 18002.
  • 7
    Mavraki E, Gray IC, Bishop DT, Spurr NK. Germline BRCA2 mutations in men with breast cancer. Br J Cancer 1997; 76: 142831.
  • 8
    Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 1997; 60: 3139.
  • 9
    CHEK2 Breast Cancer Consortum. Low penetrance susceptibility of breast cancer due to CHEK2*1100delC in non-carriers of BRCA1 or BRCA2 mutations. Nature Genet 2002; 31: 5559.
  • 10
    Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002; 71: 4328.
  • 11
    Lee JS, Collins KM, Brown AL, Lee CH, Chung JH. hCds-1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 2000; 404: 201204
  • 12
    Lee SB, Kim SH, Bell DW, Wahrer DC, Schiripo TA, Jorczak MM, Sgroi DC, Garber JE, Li FP, Nichols KE, Varley JM, Godwin AK, Shannon KM, et al. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni syndrome. Cancer Res 2001; 61: 80627.